Evidence map›Paper›PMID 30522410›Full record

ArticleHIV clinical trials2018

Natural control of HIV infection in young women in South Africa: HPTN 068.

Mariya V Sivay, Jessica M Fogel, Jing Wang, Yinfeng Zhang, Estelle Piwowar-Manning, William Clarke, Autumn Breaud, Joel Blankson, Erica L Hamilton, Kathleen Kahn and 6 more

Open access · greenAbstract read
In one paragraph

Article in HIV clinical trials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Mariya V Sivaya Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland , USA.
Jessica M Fogela Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland , USA.ORCID 0000-0003-3143-9000
Jing Wangb Statistical Center for HIV/ AIDS Research & Prevention (SCHARP) , Seattle , Washington , USA.
Yinfeng Zhanga Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland , USA.
Estelle Piwowar-Manninga Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland , USA.
William Clarkea Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland , USA.ORCID 0000-0001-9665-4786
Autumn Breauda Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland , USA.
Joel Blanksonc Department of Medicine , Johns Hopkins University School of Medicine , Baltimore , Maryland , USA.
Erica L Hamiltond Science Facilitation Department , FHI 360 , Durham , North Carolina , USA.
Kathleen Kahne MRC/Wits Rural Public Health and Health, Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences , University of the Witwatersrand , Johannesburg , South Africa.
Amanda Selinf University of North Carolina at Chapel Hill, Carolina Population Center , Chapel Hill , North Carolina , USA.
F Xavier Gomez-Olivee MRC/Wits Rural Public Health and Health, Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences , University of the Witwatersrand , Johannesburg , South Africa.ORCID 0000-0002-4876-0848
Catherine MacPhaile MRC/Wits Rural Public Health and Health, Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences , University of the Witwatersrand , Johannesburg , South Africa.ORCID 0000-0002-0614-0157
James P Hughesh Department of Biostatistics , University of Washington , Seattle , Washington , USA.
Audrey Pettifore MRC/Wits Rural Public Health and Health, Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences , University of the Witwatersrand , Johannesburg , South Africa.
Susan H Eshlemana Department of Pathology , Johns Hopkins University School of Medicine , Baltimore , Maryland , USA.ORCID 0000-0002-4587-791X
Johns Hopkins University · USUniversity of the Witwatersrand · ZAUniversity of North Carolina at Chapel Hill · USCancer Research And Biostatistics · USFamily Health International 360 · USUniversity of Washington · US

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI Sinead Delany-Moretlwe, RAPHAEL J LANDOVITZ · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit 2024 SupplementUM1AI069423 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, MINA CHRISTINE HOSSEINIPOUR · 2012 to 2026
$71.8M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Laboratory and Statistical Development of Cross-Sectional HIV Incidence AssaysR01AI095068 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2011 to 2021
$6.6M
Effects of Cash Transfer and Community Mobilization in Young South African WomenR01MH087118 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PETTIFOR, AUDREY · 2009 to 2013
$2.5M
NIAID NIH HHS R01 AI095068NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1 AI069423NICHD NIH HHS P2C HD050924NIMH NIH HHS R01 MH087118
6 · The paper itself

Abstract

backgroundSome individuals control HIV replication without antiretroviral (ARV) therapy.

objectiveTo analyze viral suppression in young women in rural South Africa enrolled in a trial evaluating a behavioral intervention for HIV prevention.

methodsPlasma samples were obtained from women ages 13-24 (81 infected at enrollment, 164 seroconverters). ARV testing was performed using an assay that detects 20 ARV drugs. Women were classified as viremic controllers if they were virally suppressed for ≥12 months with no ARV drug use.

resultsSamples from 216/245 (88.2%) women had no ARV drugs detected at their first HIV-positive visit. Thirty-four (15.7%) of the 216 women had a viral load <2,000 copies/mL. Fifteen of the 34 women were followed for ≥12 months; 12 were virally suppressed with no ARV drugs detected during follow-up. These women were classified as viremic controllers (overall: 12/216 = 5.6%). The median CD4 cell count at the first HIV-positive visit was higher among the 12 controllers than among the 204 women who were not using ARV drugs (759 vs. 549 cells/mm

conclusionsIn this cohort, 5.6% of women who were not using ARV drugs had sustained viral suppression. This represents a minimum estimate of the frequency of viremic controllers in this cohort, since some women were not followed long enough to meet the criteria for classification.

Indexed as

AdolescentAnti-Retroviral AgentsCD4 Lymphocyte CountCD4-Positive T-LymphocytesCohort StudiesFemaleHIV InfectionsHumansSouth AfricaViral LoadViremiaYoung AdultAnti-Retroviral AgentsHIVNatural controlSouth AfricaViremic controllersYoung women

Identifiers

PMID30522410
PMCPMC6442735
OpenAlexW2904336785

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.